Literature DB >> 21596262

Macular infarction after inadvertent intracameral cefuroxime.

Farhan Qureshi1, David Clark.   

Abstract

UNLABELLED: We present the case of a 70-year-old patient who had uneventful cataract surgery. Because of a procedural mishap, the patient received an excess dose of intracameral cefuroxime of approximately 62.5 mg. Two weeks postoperatively, evidence of macular infarction with cystoid macular edema was seen on fundus fluorescein angiography. The patient was treated with 4.0 mg of intravitreal triamcinolone, but the visual acuity failed to improve; the final pinhole acuity was 3/60. Based on the postoperative progress, we speculate that a delayed mechanism of vascular toxicity is implicated. The importance of systematic procedures to reduce the risk for mistakes is emphasized, especially for a procedure such as cataract surgery where efficiency is increasingly important. FINANCIAL DISCLOSURE: Neither author has a financial or proprietary interest in any material or method mentioned.
Copyright © 2011 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21596262     DOI: 10.1016/j.jcrs.2011.03.032

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  16 in total

1.  Effect of intracameral carbachol given during cataract surgery on macular thickness.

Authors:  Mehmet Demir; Ersin Oba; Burcu Dirim; Efe Can; Mahmut Odabasi; Erhan Ozdal
Journal:  Int Ophthalmol       Date:  2012-05-11       Impact factor: 2.031

2.  Retinal toxicity after intracameral use of a standard dose of cefuroxime during cataract surgery.

Authors:  Céline Faure; Daniel Perreira; Isabelle Audo
Journal:  Doc Ophthalmol       Date:  2014-10-16       Impact factor: 2.379

3.  Combination of lidocaine gel and povidone-iodine to decrease acquired infections in procedures performed using topical anesthesia.

Authors:  Julia Xia; Riley J Lyons; Mung Yan Lin; Yousuf M Khalifa; Christopher N LaRock
Journal:  J Cataract Refract Surg       Date:  2020-07       Impact factor: 3.351

Review 4.  Intracameral cefuroxime: prophylaxis of postoperative endophthalmitis after cataract surgery.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2013-02       Impact factor: 9.546

5.  Transient macular edema after intracameral injection of a moderately elevated dose of cefuroxime during phacoemulsification surgery.

Authors:  David C Wong; Michael D Waxman; Lisa J Herrinton; Neal H Shorstein
Journal:  JAMA Ophthalmol       Date:  2015-10       Impact factor: 7.389

6.  A sudden total loss of vision after routine cataract surgery.

Authors:  S Lartey; P Armah; A Ampong
Journal:  Ghana Med J       Date:  2013-06

7.  Budget impact assessment of Aprokam® compared with unlicensed cefuroxime for prophylaxis of post-cataract surgery endophthalmitis.

Authors:  Christine Purslow; Keith Davey; Mildred Johnson; Guilhem Pietri; Gaurav Suri
Journal:  BMC Ophthalmol       Date:  2015-07-08       Impact factor: 2.209

Review 8.  Risks of Cefuroxime Prophylaxis for Postcataract Endophthalmitis.

Authors:  Khaled A Al-Abduljabbar; Donald U Stone
Journal:  Middle East Afr J Ophthalmol       Date:  2017 Jan-Mar

9.  Postcataract endophthalmitis prophylaxis using irrigation, incision hydration, and eye pressurization with vancomycin.

Authors:  Lee P Schelonka; Margaret A SaBell
Journal:  Clin Ophthalmol       Date:  2015-07-17

10.  Effect of Intracameral Ophthalmic Cefuroxime Solution (Aprokam®) in the Prophylaxis of Cataract Surgery in Patients with Keratoplasty.

Authors:  Mustafa Erdoğan Cicik; Cezmi Doğan; Osman Şevki Arslan
Journal:  Balkan Med J       Date:  2018-03-15       Impact factor: 2.021

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.